{"article_title": "Baxalta-Shire news: Reaction to the mergerMedCity News", "article_keywords": ["wants", "reaction", "business", "baxaltashire", "million", "mergermedcity", "system", "ventures", "health", "services", "partner", "today", "care"], "article_url": "http://medcitynews.com/2016/01/baxalta-shire-merger-news/", "article_text": "TOP STORIES\n\nHere\u2019s the day-after interpretation and fallout from the Baxalta-Shire merger:\n\nShire CEO Flemming Ornskov \u201cfaces a career-defining challenge\u201d to make the combined companies a giant in the rare-disease space. Much of the skepticism focuses on concerns about competitive threats to Baxalta\u2019s haemophilia business. \u2013 Financial Times\n\nShire\u2019s $32 billion cash-and-stock deal appears to have rested on its evolving view of the U.S. tax code. \u2013 The Wall Street Journal\n\nShire is increasing its debt to over two times EBITDA, from less than one currently. \u2013 Reuters\n\nTwo things appear to concern analysts. First, there are some extremely ambitious targets for savings from the merger. Second, it is difficult to see how the coming together of these two quite different businesses can accelerate growth for the combined entity. \u2013 Irish Times\n\nPreserving the \u201ctax-free status\u201d of the Baxalta spinoff was a key component of the takeover discussions. \u2013 The New York Times\n\nThe Aetna-Humana and Anthem-Cigna mergers just got tougher: about 15 state attorneys general have joined the Justice Department\u2019s probe of the deals. \u2013 Reuters\n\nLooking for JP Morgan Healthcare coverage? Through Thursday, MedCity News will send out a separate morning update and newsletter with all of our reporting. Anyone who subscribes to our daily e-newsletter will get the JPM e-mail. Sign up here today (our JPM e-mail will be sent around 9 a.m. Eastern).\n\nLIFE SCIENCES\n\nMedtronic will spend the $9.3 billion from the Covidien integration to pay down debt as it looks to regain its A credit rating and return at least half of cash through dividends or buybacks. \u2013 MassDevice\n\nMylan filed for FDA approval its generic version of GlaxoSmithKline\u2019s Advair. Expect it on the market by next year. \u2013 Reuters\n\nNestle added another $120 million into Seres Therapeutics, which is developing \u201chealthy gut\u201d drugs to treat the likes of Clostridium difficile infection (CDI) and inflammatory bowel disease. \u2013 Reuters\n\nDr. Joshua Resnick, former president and managing partner at MRL Ventures Fund, has joined SV Life Sciences as a partner. \u2013 PRNewswire\n\nHeart-failure device company V-Wave, which is developing a implantable interatrial shunt, closed $28 million from investors including Johnson & Johnson and Edwards Lifesciences. \u2013 Business Wire\n\nVascular Pharmaceuticals raised $3 million to increase the size of a clinical trial for its diabetic nephropathy treatment. \u2013 Triangle Business Journal\n\nPAYERS-PROVIDERS\n\nBritish doctors staged a 24-hour walkout \u2013 the first strike in 40 year \u2013 over plans by the government to restructure their pay. More are coming. \u2013 Reuters\n\nProblems with hospital M&A in Oregon: National Nurses United wants the state\u2019s attorney general to block the merger of Providence Health & Services and St. Joseph Health System. \u2013 Portland Business Journal\n\nTECHNOLOGY\n\nEzekiel \u201cZeke\u201d J. Emanuel has become a venture partner at Oak HC/FT. \u2013 Business Wire\n\nAnother app looking to disrupt insurance brokerage: Switzerland\u2019s FinanceFox raises $5.5 million backs by Salesforce Ventures. \u2013 TechCrunch\n\nPOLITICS\n\nHere\u2019s the background on 35 CPT codes the American Telemedicine Association wants reimbursed for rehabilitation, physical therapy, home dialysis, critical care services and behavioral health. \u2013 mHealthIntelligence\n\nDr. Robert Califf FDA commissioner vote could be today (smooth sailing still expected). \u2013 STAT\n\nKentucky\u2019s new Republican governor, Matt Bevin, has notified the Obama administration that he plans to dismantle the state\u2019s ObamaCare marketplace.- The Hill\n\nHey, no fair! Only industry can game the system! Payers are compaining that Obamacare customers are buying coverage only after they find out they\u2019re ill and need expensive care. \u2013 Politico\n\nMeet the 121 new Medicare Accountable Care Organizations (we\u2019re now up to 477). \u2013 Health and Human Services (h/t HISTalk)\n\nA LITTLE BIT EXTRA\n\nThe many faces of the late David Bowie. \u2013 Reddit", "article_metadata": {"description": "Also, learn how consumers are gaming Obamacare, the next moves to get better reimbursement for telemedicine, and meet some impressive new venture partners.", "generator": "WordPress 4.5.2", "og": {"site_name": "MedCity News", "description": "Also, learn how consumers are gaming Obamacare, the next moves to get better reimbursement for telemedicine, and meet some impressive new venture partners.", "title": "Morning Read: Full Baxalta-Shire repercussions, a higher-bar for Aetna and Cigna mergers", "locale": "en_US", "image": "http://medcitynews.com/wp-content/uploads/2016/01/FlemmingOrnskov.jpg", "updated_time": "2016-01-12T07:56:01-04:00", "url": "http://medcitynews.com/2016/01/baxalta-shire-merger-news/", "type": "article"}, "twitter": {"image": "http://medcitynews.com/wp-content/uploads/2016/01/FlemmingOrnskov.jpg", "description": "Also, learn how consumers are gaming Obamacare, the next moves to get better reimbursement for telemedicine, and meet some impressive new venture partners.", "card": "summary", "title": "Baxalta-Shire news: Reaction to the merger"}, "robots": "noodp", "fb": {"app_id": 148725768475669}, "google-site-verification": "xudQg7nxVR9ifmMTY4Tf-0wVtX9b6rWLQd0utCweGOc", "keywords": "weight loss, obesity, overweight,diabetes,massachusetts,medical devices,obesity,startups,healthcare innovation, medcity news,medcity news,san francisco, startups, life sciences,accelerator,rock health,startup advice,startup funding,patient monitoring system, motion sensors ,dc,healthcare it,washington,foodborne pathogens, diagnostics company, diagnostic platforms,minimally invasive surgery, laser surgery,cambridge,dealflow,hospitals,wellpoint, healthways, health and wellness, employee wellness programs,investing,wellness,medtronic, shanghai innovation center, china, r&d,china,mdt,minneapolis,minnesota,publics,twin cities,ulcerative colitis, abbott labs, humira,abbott labs,doctors,pharmaceuticals,skin disorders, pharmaceuticals, md anderson cancer center,cancer,texas,renal denervation, st. jude medical,st. jude medical,stj,emr, ehr, electronic health records, electronic medical records, certified emr,certified emr,ehr,electronic health records,electronic medical records,advanced cellular technology,amyotrophic lateral sclerosis,embryonic stem cells,geron corporation,lou gehrig\\'s disease,macular degeneration,regenerative medicine,spinal cord damage,value-based healthcare system, obamacare, fee-for-service model,california,cleveland,health insurance,insurance,ohio,pennsylvania,politics,cancer treatment options library, aetna, aet, healthcare it,aet,aetna,health it,phi,philadelphia,Baxalta, Shire, , MedCity News", "article": {"section": "Daily", "tag": "Shire", "published_time": "2016-01-12T07:55:52-04:00", "modified_time": "2016-01-12T07:56:01-04:00"}, "viewport": "width=device-width,initial-scale=1.0,width=device-width,user-scalable=no,minimum-scale=1.0,maximum-scale=1.0"}, "_id": "\"57477af36914bd0286fd3470\"", "article_summary": "\u2013 ReutersProblems with hospital M&A in Oregon: National Nurses United wants the state\u2019s attorney general to block the merger of Providence Health & Services and St. Joseph Health System.\n\u2013 TechCrunchPOLITICSHere\u2019s the background on 35 CPT codes the American Telemedicine Association wants reimbursed for rehabilitation, physical therapy, home dialysis, critical care services and behavioral health.\n\u2013 ReutersDr. Joshua Resnick, former president and managing partner at MRL Ventures Fund, has joined SV Life Sciences as a partner.\nTOP STORIESHere\u2019s the day-after interpretation and fallout from the Baxalta-Shire merger:Shire CEO Flemming Ornskov \u201cfaces a career-defining challenge\u201d to make the combined companies a giant in the rare-disease space.\nPayers are compaining that Obamacare customers are buying coverage only after they find out they\u2019re ill and need expensive care."}